Tributary Capital Management LLC Has $51.64 Million Position in Integer Holdings Corporation $ITGR

Tributary Capital Management LLC increased its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 92.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 499,776 shares of the medical equipment provider’s stock after purchasing an additional 240,226 shares during the period. Integer accounts for 2.4% of Tributary Capital Management LLC’s holdings, making the stock its 5th biggest holding. Tributary Capital Management LLC owned about 1.43% of Integer worth $51,642,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Salomon & Ludwin LLC purchased a new stake in Integer during the third quarter worth $26,000. Global Retirement Partners LLC raised its position in shares of Integer by 293.8% in the 3rd quarter. Global Retirement Partners LLC now owns 319 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 238 shares in the last quarter. CWM LLC lifted its stake in shares of Integer by 46.1% during the 2nd quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 112 shares during the last quarter. MAI Capital Management boosted its position in Integer by 220.9% during the second quarter. MAI Capital Management now owns 369 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 254 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in Integer by 210.5% in the second quarter. EverSource Wealth Advisors LLC now owns 534 shares of the medical equipment provider’s stock worth $66,000 after purchasing an additional 362 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Down 0.1%

Integer stock opened at $80.77 on Thursday. The business’s 50-day simple moving average is $72.51 and its two-hundred day simple moving average is $94.88. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The company has a market cap of $2.83 billion, a PE ratio of 33.79, a PEG ratio of 0.74 and a beta of 0.78. Integer Holdings Corporation has a fifty-two week low of $62.00 and a fifty-two week high of $146.36.

Integer (NYSE:ITGR) last released its earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.Integer’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.43 earnings per share. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. Equities analysts anticipate that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its board has approved a stock buyback plan on Tuesday, November 4th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the medical equipment provider to buy up to 8.3% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Insider Buying and Selling at Integer

In other Integer news, EVP Diron Smith acquired 1,116 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were acquired at an average cost of $67.19 per share, with a total value of $74,984.04. Following the acquisition, the executive vice president directly owned 7,698 shares of the company’s stock, valued at approximately $517,228.62. The trade was a 16.96% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Tommy P. Thomas sold 884 shares of the business’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $70.15, for a total transaction of $62,012.60. Following the transaction, the vice president owned 3,596 shares of the company’s stock, valued at $252,259.40. This represents a 19.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have acquired 5,843 shares of company stock valued at $384,771. 2.16% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Citigroup increased their target price on shares of Integer from $69.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Benchmark reaffirmed a “hold” rating on shares of Integer in a research report on Friday, October 24th. Wall Street Zen downgraded Integer from a “buy” rating to a “hold” rating in a report on Saturday, January 3rd. Piper Sandler dropped their price target on Integer from $155.00 to $82.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Finally, KeyCorp decreased their price objective on shares of Integer from $145.00 to $133.00 and set an “overweight” rating for the company in a research report on Tuesday, October 21st. Four investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Integer presently has a consensus rating of “Hold” and an average price target of $98.38.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.